FDA Inspection 1238045 — Boehringer Ingelheim Espana S.A.
The FDA completed an inspection of Boehringer Ingelheim Espana S.A. on June 30, 2023 in Sant Cugat Del Valles. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 30, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sant Cugat Del Valles (Spain)
Additional Details
Mutual Recognition Agreement (MRA)